Dualitas

Dualitas Therapeutics

The company develops bispecific antibody therapies for patients with autoimmune and allergic diseases using a cell-surface proximity screening engine.

Dualyx

This company develops immune-modulating therapies targeting regulatory T cells to treat patients with autoimmune diseases.

Ducentis

This biotechnology company develops fusion protein therapies targeting the CD200 receptor to treat patients with inflammation and autoimmune diseases.

Attovia Therapeutics

The company develops biparatopic biologics to treat patients with immune-mediated diseases and cancer through a modular protein design platform.

Bambusa Therapeutics

The company develops bispecific antibodies for patients with immunological and inflammatory disorders.

Reverb Therapeutics

This biotechnology company develops bispecific antibody therapies that redirect the body's natural cytokines to treat patients with cancer and autoimmune diseases.

Caldera Therapeutics

This clinical-stage biotechnology company develops bispecific antibodies to treat patients with inflammatory bowel disease and other immune-mediated conditions.

Belenos Biosciences

This clinical-stage biotechnology company develops long-acting bispecific antibody therapeutics for patients with chronic inflammatory diseases such as asthma and atopic dermatitis.